Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite

Cairo University (CU)

Status: Not yet enrolling

Conditions: Caries Class II

Treatments: Drug: 3M Filtek Z250 XT Universal; Drug: Beautifil II LS (Low-Shrinkage)

Study type: Interventional

Funder types: Other

Identifiers

NCT05949502

Low shrinkage giomer

Details and patient eligibility

About

A clinical trial, comparing the clinical performance and occlusal wear resistance of two different restorative materials in restoring proximal caries in permanent posterior teeth. One is based on giomer technology and the other is nano-hybrid resin composite.

Full description

The aim of this study is to assess clinical performance and occlusal wear resistance of low shrinkage Giomer and Nanohybrid Resin Composite in proximal restorations using revised FDI (World Dental Federation) criteria and digital intra-oral scanner.

Two different restorative materials will be evaluated after two years for fracture, retention and occlusal wear. Furthermore, the rest of the revised FDI Criteria including functional (marginal adaptation, proximal contact point, form and contour, occlusion and occlusal wear) , biological (caries at restoration margin (CAR), dental hard tissue defects at restoration margin and postoperative hypersensitivity/pulp status) and esthetic properties (surface luster and surface texture, marginal staining and color match) will be also evaluated.

The first material is based on the giomer technology which is a true hybrid between nano-hybrid resin composite and glass ionomer. The comparator will be a nano-hybrid resin composite.

Examination and selection of all patients will be done. Teeth with proximal, primary carious lesions will be selected. Rubber dam isolation will be done followed by preparation of Class II cavities and placement of restorative material according to the randomization sequence.

Low-shrinkage bioactive material will be applied according to the manufacturer's instructions. For the comparator group, nano-hybrid resin composite will be also applied according to the manufacturer's instructions. Restorations will evaluated at baseline, after six, 12, 18 and 24 months.

Enrollment: 26 estimated patients

Sex: All

Ages: 19 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Inclusion criteria for patients

  • Patient's age ranging from 19-30
  • Good oral hygiene.
  • Patients who have stable occlusion.
  • Patients who could be present for further periodic follow-ups.
  • Possibility for application of rubber dam during restoration.
  • Patient compliance.

• Inclusion criteria for Teeth

  • Vital first and second molars, with compound Class II lesions.
  • The selected teeth should be in occlusion with natural dentition and having proximal contact with adjacent teeth.
  • Healthy periodontium.

Exclusion criteria

• Exclusion criteria for patients

  • Poor oral hygiene.
  • Patients with high caries index or high plaque index.
  • Patients with periodontal problems.
  • Heavy bruxism habit or presence of any parafunctional habits.
  • Any allergic reactions against any components of the materials to be used in the study.
  • History of severe medical complications such as xerostomia.
  • Pregnant or lactating women.
  • Participating in another clinical trial.

• Exclusion criteria for teeth

  • Fractured or evidently cracked teeth.
  • Defective restorations adjacent or opposite the selected tooth for research.
  • Atypical extrinsic staining of teeth.
  • Teeth with defects or lesions requiring other operative interventions.
  • Teeth with pulpal pain.
  • Teeth with periapical lesions.
  • Root Canal treated teeth.
  • Mobile Teeth.
  • Non-functioning teeth with no opposing tooth.
  • Signs of severe attrition.
  • Heavy occlusion.
  • Periodontally affected teeth.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

26 participants in 2 patient groups

Low shrinkage giomer.

Experimental group

Description:

Low-shrinkage bioactive material (giomer) will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. This will be followed by light curing of each increment for 40 seconds using light curing unit till the whole cavity is filled.

Treatment:

Drug: Beautifil II LS (Low-Shrinkage)

Nano-hybrid resin composite

Active Comparator group

Description:

Nano-hybrid resin composite will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. Composite increments will be adapted obliquely on each cusp. This will be followed by light curing for 40 seconds using light curing unit of each increment till the whole cavity is filled.

Treatment:

Drug: 3M Filtek Z250 XT Universal